Kilic et al. reported that plasma omentin levels did not differ between MS patients and control subjects, and in all subjects, omentin was positively correlated with triglyceride levels and negatively correlated with HDL-C levels [30]. The gene discussed is ITLN1; the disease is myeloid sarcoma.